Krystal Biotech, Inc. (KRYS)
收市後：
- Insider Monkey
Krystal Biotech (KRYS) Surged as it Beat the Streat Estimates with Wide Margin
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” first-quarter 2024 investor letter. A copy of the letter can be downloaded here. In the quarter the fund returned 5.77% (net), compared to a 7.58% return for the Russell 2000 Growth Index. Despite a decline in many equity markets in […]
- Investor's Business Daily
Krystal Biotech Stock Sees RS Rating Jump To 91
Krystal Biotech shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.
- Insider Monkey
Is Krystal Biotech, Inc. (NASDAQ:KRYS) the Premier Gene Therapy Stock for Your Portfolio?
We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Krystal Biotech, Inc. (NASDAQ:KRYS) is the premier gene therapy stock for your portfolio. Gene therapy involves treating illnesses by modifying, replacing, or supplementing faulty or missing genes responsible for a disease. This approach […]
